Swiss Electrical Stock News

Q1 earnings set the tone for Swiss Re stock Swiss Re (SWX:SREN) put its first quarter on the table on May 7, reporting net income of US$1,506 million versus US$1,267 million a year earlier, alongside its Q1 2026 earnings call. See our latest analysis for Swiss Re. Despite the stronger Q1 net income, the stock has come under pressure, with the share price down 10.6% over the past month and the 1 year total shareholder return declining 14.08%, although the 5 year total shareholder return of...

INFICON Holding (SWX:IFCN) is back in focus after recent analyst updates and an annual general meeting where shareholders backed all proposals and approved a CHF 2.00 dividend, which has reinforced attention on the stock. See our latest analysis for INFICON Holding. INFICON Holding's recent AGM decisions and analyst updates come as the share price trades at CHF157.0, with a 1 month share price return of 36.8% and a 1 year total shareholder return of 63.0%, suggesting momentum has been...

Earlier this week, Sensirion Holding reported revenue growth of 18.58% alongside a zero-debt balance sheet and solid liquidity, reinforcing its financial strength. This combination of accelerating top-line performance and a clean capital structure adds an extra layer of resilience to Sensirion’s existing growth story. Next, we’ll examine how this strong revenue momentum and debt-free position may reshape Sensirion Holding’s existing investment narrative. Capitalize on the AI...

ABB (SWX:ABBN) has announced around US$200 million of investment in its European medium voltage operations, including a new facility in Italy and upgrades across several factories, to support demand for advanced grid technologies. See our latest analysis for ABB. ABB’s recent US$200 million grid investment program comes as the stock trades at CHF82.02, with a 30-day share price return of 14.17% and a 1-year total shareholder return of 78.50%, signalling strong momentum across both shorter and...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Readers hoping to buy Burkhalter Holding AG ( VTX:BRKN ) for its dividend will need to make their move shortly, as the...

Swiss Re AG ( VTX:SREN ) last week reported its latest first-quarter results, which makes it a good time for investors...

Recent share performance and business snapshot Clariant (SWX:CLN) has come into focus after a recent pullback, with the stock down about 7% over the past month and roughly 7% over the past 3 months, prompting investors to reassess its fundamentals. The Switzerland based specialty chemicals company operates across three main segments: Care Chemicals, Catalysts, and Adsorbents & Additives, serving customers across Europe, the Americas, Asia and the Middle East & Africa. See our latest analysis...

The European stock market recently experienced a volatile week, with modest gains in the pan-European STOXX Europe 600 Index, as investor sentiment was buoyed by easing geopolitical tensions and strong corporate earnings. However, looming threats of increased tariffs from the U.S. added pressure to markets. In this context, identifying undervalued stocks becomes crucial for investors seeking opportunities that are potentially trading below their intrinsic value amidst fluctuating market...

In early May 2026, ams-OSRAM reported first-quarter sales of €796 million alongside a larger net loss and issued guidance for slightly softer full-year 2026 revenue due to business divestments and foreign-exchange effects. At the same time, the company highlighted progress in its Digital Photonics pivot, including a development partnership targeting AI data centers and micro LED commercialization, which has drawn renewed attention to its semiconductor portfolio. We’ll now examine how this...

Valiant Holding AG reported first-quarter 2026 results with net interest income of CHF 100.64 million and net income of CHF 33.24 million, both slightly higher than a year earlier. Despite this modest improvement, investors focused on the bank’s elevated debt levels and challenging revenue trends, which raised concerns about its financial flexibility and resilience. We’ll now examine how these weaker-than-expected earnings, alongside concerns over the high debt-to-equity ratio, shape Valiant...

Why Kuros Biosciences (SWX:KURN) is on investors’ radar today Kuros Biosciences (SWX:KURN) has drawn attention after recent share price pressure, with the stock showing a 15.1% decline over the past month and a 20.2% decline over the past 3 months. See our latest analysis for Kuros Biosciences. At the latest share price of CHF20.12, Kuros Biosciences shows weaker short term momentum, with a 1 month share price return of 15.1% decline and a year to date share price return of 24.6% decline,...

Novartis has started construction on a new radioligand therapy manufacturing facility in Denton, Texas. The Denton site expands the company’s US network for advanced cancer treatments and is part of a broader multi year, multi billion dollar US investment plan. The project is expected to support access to personalized cancer therapies and create jobs in bioengineering and advanced manufacturing. For investors following Novartis (SWX:NOVN), the Denton build out comes as the stock trades...

If you are asking whether UBS Group is priced attractively right now, the starting point is to look closely at what the current share price might already be assuming. The stock last closed at CHF 35.03, with returns of 1.5% over 7 days, 8.1% over 30 days, a 8.2% decline year to date, and gains of 38.4% over 1 year, 120.8% over 3 years and 189.1% over 5 years. Recent headlines have focused on UBS Group's role as a major global banking and wealth management group, including its ongoing...

Roche Holding (SWX:ROP) has entered a definitive agreement to acquire PathAI, a US-based provider of digital pathology and AI-powered diagnostic technologies. The deal is intended to expand Roche's digital pathology offering and support AI-driven diagnostics and precision oncology. The acquisition also aims to support biopharma partners with AI-enabled services in clinical trials and translational research. For Roche, which operates across pharmaceuticals and diagnostics, the PathAI deal...

If you are wondering whether Temenos is priced fairly or if the current share price leaves room for upside, it helps to start by looking closely at what the market has been paying for this stock recently. Temenos shares recently closed at CHF 74.20, with returns of 0.4% over 7 days, 2.3% over 30 days, a 9.0% decline year to date, and 22.6% over the past year. Together, these figures present a mixed picture of changing expectations and risk perception. Recent coverage of Temenos has focused...

If you are wondering whether Alcon at around $49.17 is starting to look like value after a tough spell, this breakdown will help you frame the opportunity and the risks. The stock has faced sharp share price pressure, with returns of a 15.5% decline over 7 days, a 19.7% decline over 30 days, a 22.6% decline year to date and a 37.9% decline over 1 year, as well as a 29.9% decline over 3 years and a 19.2% decline over 5 years. Recent coverage has focused on how this sustained weakness has put...

Vaudoise Assurances Holding SA ( VTX:VAHN ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is...

The investors in ams-OSRAM AG 's ( VTX:AMS ) will be rubbing their hands together with glee today, after the share...

Swiss Re (SWX:SREN) has wrapped up FY 2025 with fourth quarter revenue of US$10.6b and basic EPS of US$2.43, capping a trailing twelve month EPS of US$15.67 on total revenue of US$42.6b. Over recent quarters the company has seen revenue in a tight band between US$10.5b and US$11.0b, while quarterly EPS ranged from US$0.35 in Q3 2024 to US$4.85 in Q3 2025, giving investors a clear view of how earnings have tracked through the year. With net profit margins over the last twelve months at 10.8%...

ABB is expanding its role in digital twin technology for the marine industry, focusing on real time optimization and asset monitoring. The company is deepening its digital solutions offering for ship operators, adding to its traditional electrification and automation capabilities. This move highlights ABB's push into asset lifecycle management within a growing segment of the maritime market. For investors tracking SWX:ABBN, this push into marine digital twins sits alongside a share price of...

OC Oerlikon Corporation AG recently completed a CHF 200 million senior unsecured fixed-rate bond issuance carrying a 2.125% coupon and maturing in May 2031. This new bond reshapes the group’s funding mix and liquidity position, which may influence how investors assess its balance sheet strength and flexibility. We’ll now examine how this CHF 200 million senior unsecured bond issue may alter OC Oerlikon’s existing investment narrative and outlook. The best AI stocks today may lie beyond...

Adecco Group (SWX:ADEN) is back in focus after finalizing its 2025 scrip dividend, with 53.01% of shareholders choosing new shares and 5,268,324 shares issued alongside the cash payout on 7 May 2026. See our latest analysis for Adecco Group. Even with the scrip dividend in place, Adecco Group's share price at CHF18.27 reflects weak momentum. The 90 day share price return is 20.36%, and the 1 year total shareholder return shows a 16.87% decline, suggesting sentiment has softened despite the...

As the European market navigates a landscape marked by stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index has remained relatively stable, reflecting cautious investor sentiment amid ongoing economic uncertainties. Against this backdrop, growth companies with high insider ownership can offer unique insights into potential investment opportunities, as insider stakes often signal confidence in a company's long-term prospects despite broader...